Friday, 19 July 2019

Pharma News

  • Bayer to buy Chinese firm Dihon Pharma

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 Feb, 2014

    Singapore: Germany's leading pharmaceutical company, Bayer has said that it is planning to acquire Chinese pharma firm Dihon Pharmaceutical Group as part of its global growth plan. The pha...Read more

  • ScinoPharm CEO retires, firm's VP to succeed

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jul, 2014

    Singapore: Taiwan-based pharmaceutical company ScinoPharm announced the retirement of its chief executive officer, Dr Jo Shen. Dr Shen would be retiring by the end of July, following 17 yea...Read more

  • Diabetes specialist Amylin is on sale for $4.3bn

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2012

    Singapore: Diabetes company Amylin, which steered away a $3.5 billion takeover bid from Bristol-Myers Squibb (BMS) earlier this year, is expected to enter into a second round of bidding in ...Read more

  • Boehringer heart drug is particularly effective in Asian population

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

    Singapore: Boehringer Ingelheim has reported that in Asian populations, Pradaxa (dabigatran etexilate) offers considerable benefits for the management of patients with atrial fibrillation (...Read more

  • Sanford-Burnham, Daiichi form new alliance

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 May, 2014

    Singapore: US based Sanford-Burnham Medical Research Institute and Japan's Daiichi Sankyo have formed a three year discovery and pre-clinical drug development partnership for cardiovascular...Read more

  • Boehringer, Eli Lilly to evaluate Trajenta for type 2 diabetes

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 21 Mar, 2013

    Singapore: Boehringer Ingelheim and Eli Lilly have initiated phase IIIb trial to evaluate the glycaemic efficacy and safety of linagliptin in type 2 diabetes patients with prevalent albumin...Read more

  • Pharma giants warn Korea of low drug pricing

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jul, 2014

    Singapore: International pharma companies are concerned about the low pricing of their drugs in the Korean markets and have warned Seoul that they are holding back new medicines from the co...Read more

  • Astrazeneca, China university in research deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

    Singapore: AstraZeneca has signed a research collaboration with Fudan University, one of China's leading academic institutions in the area of cardiovascular diseases (CVDs). CVDs are a lead...Read more

  • India to soon decide on FDI policy in pharma

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2013

    Singapore: Ahead of the raging issue of Foreign Direct Investment (FDI) in the pharmaceutical sector in India, the country's finance minister P chadambaram has said that the government woul...Read more

  • Bio & Medical Korea 2014: Global healthcare tourism event

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Bio and Medical Korea 2014 an international event of the medical industry, was held over three days beginning on May 28 at Kintex in Gyeonggi Province, northwest of Seoul. The ev...Read more

  • Takeda strives to enter Europe's type 2 diabetes market

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 21 Jun, 2012

    Singapore: Japan-based Takeda Global Research & Development Centre has received confirmation of the acceptance of submissions of marketing authorisation applications (MAAs) from the Eur...Read more

  • AstraZeneca, BMS gets positive regulatory feedback on Type 2 diabetes drug

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 29 Nov, 2013

    Singapore: Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has provided AstraZeneca and Bristol-Myers Squibb a positive opinion recommending app...Read more

  • Biocon's earnings surge in Q1 FY16

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2015

    Biocon announced that it has delivered a strong consolidated financial performance for Q1 FY16. Commenting on the quarterly performance and highlights, Chairperson and Managing Director, K...Read more

  • Filipino pharma industry to grow by 4.5 percent: IMS Health

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2015

    Singapore: According to a recent report released by IMS Consulting for the Pharmaceutical Healthcare Association of the Philippines (PHAP), the country's pharmaceutical industry is projecte...Read more

  • Who will wear the CSL mantle?

    Pharma |  Influencers | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2012

    Singapore: Current president of CSL Behring, Mr Paul Perreault, will be the new CEO of the firm after Dr Brian McNamee steps down in July 2013. Dr Brian McNamee will leave CSL in July 2013 ...Read more

  • AstraZeneca's CFO quits to join BG Group

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2013

    Singapore: AstraZeneca's chief financial officer Mr Simon Lowth is going to quit the company to join in the same role at BG Group. Mr Lowth, 51, will address the challenges that the BG Grou...Read more

  • Novartis under fire from Tasigna allegations

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2014

    Singapore: Swiss giant Novartis Pharma's Japanese arm has prompted the Japanese health ministry to launch an investigation under possible violation of the pharmaceutical affairs law. It has...Read more

  • Golden Meditech's revenue increases by 6%

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Golden Meditech Holdings, a leading integrated healthcare enterprise in China, announced the group's interim results for the six months ended 30 September 2012.  During the in...Read more



Podcast

 

Survey Box

Is Blockchain offering a solution to the healthcare industry?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls